Sandoz and Teva Invalidate Patent and SPC of Blockbuster Apixaban
Summary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
Summary : EP 1,427,415 was assigned to BMS and is set to expire on September 17, 2022. On May 19, 2026, the…
An SPC cannot be granted for a medicinal product which is protected in the basic patent and already on the market –…